We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The antibodies are designated mAB for monoclonal and pAb for polyclonal.
pAb
Concentration
Not known
Purity
Affinity
Released in versioni
The release of the Human Protein Atlas in which the antibody was first published.
18.0
Validation summaryi
All assays through which the antibody has been validated. Assays&annotation provide a detailed description of the different assays. The pie-charts indicate degree of validation.
Immunohistochemistry is used for validating antibody reliability by assessing staining pattern in 44 normal tissues. Validation scores include Enhanced, Supported, Approved and Uncertain.
Validationi
Results of validation by standard or enhanced validation based on assessment of antibody performance in 44 normal tissues.
Standard validation results in scores Supported, Approved or Uncertain. An image representative of the antibody staining pattern is shown.
Enhanced validation results in the score Enhanced and includes two methods: Orthogonal validation and Independent antibody validation. For orthogonal validation, representative images of high and low expression are shown. For independent antibody validation, four images of each independent antibody are displayed.
Supported
Moderate-intensity axonal and diffuse/synaptic immunostaining is noticed in the olfactory bulb external plexiform layer (superficial part), neocortical layers IV and VI, piriform and entorhinal cortices (all layers), amygdala and hippocampus CA2 region. In addition, a weak diffuse/synaptic-type staining is noticed in most forebrain regions. There is no or only extremely faint staining noticed in the brainstem, with the exception of the circumventricular organ area postrema that exhibits moderate-intensity immunoreactivity. (Mouse brain)
The Human Protein Atlas project is funded
